Electromyographic activity of the diaphragm during neostigmine or sugammadex-enhanced recovery after neuromuscular blockade with rocuronium A randomised controlled study in healthy volunteers

被引:13
|
作者
Schepens, Tom [1 ]
Cammu, Guy [2 ]
Saldien, Vera [1 ]
De Neve, Nikolaas [2 ]
Jorens, Philippe G. [3 ]
Foubert, Luc [2 ]
Vercauteren, Marcel [1 ]
机构
[1] Univ Antwerp Hosp, Dept Anaesthesiol, Antwerp, Belgium
[2] Onze Lieve Vrouw Hosp, Dept Anaesthesiol & Crit Care Med, B-9300 Aalst, Belgium
[3] Univ Antwerp Hosp, Dept Crit Care Med, Antwerp, Belgium
关键词
POSTOPERATIVE PULMONARY COMPLICATIONS; MECHANICAL VENTILATION; REVERSAL; DYSFUNCTION; RISK;
D O I
10.1097/EJA.0000000000000140
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
BACKGROUND The use of neuromuscular blocking agents has been associated with severe postoperative respiratory morbidity. Complications can be attributed to inadequate reversal, and reversal agents may themselves have adverse effects. OBJECTIVE To compare the electromyographic activity of the diaphragm (EMGdi) during recovery from neuromuscular blockade using neostigmine and sugammadex. The hypothesis was that there would be better neuromuscular coupling of the diaphragm when sugammadex was used. DESIGN A randomised, controlled, parallel-group, single-centre, double-blinded study. SETTING District general hospital in Belgium. PARTICIPANTS Twelve healthy male volunteers. INTERVENTIONS Individuals were anaesthetised with propofol and remifentanil. After rocuronium 0.6 mg kg(-1), a transoesophageal electromyography (EMG) recorder was inserted. For reversal of neuromuscular blockade, volunteers received sugammadex 2 mg kg(-1) (n = 6) or neostigmine 70 mu g kg(-1) (n = 6). MAIN OUTCOME MEASURES EMGdi, airway pressure and flow were continuously measured during weaning from the ventilator until tracheal extubation. Arterial blood gas samples were obtained for PaO2 and PaCO2 analysis at the first spontaneous breathing attempt and after tracheal extubation. RESULTS During weaning, 560 breaths were retained for analysis. The median (95% CI) peak EMGdi was 1.1 (0.9 to 1.5) mu V in the neostigmine group and 1.6 (1.3 to 1.9) mV in the sugammadex group (P < 0.001). Individuals in the neostigmine group had 125 of 228 (55%) breaths with associated EMGdi at least 1 mV vs. 220 of 332 (66%) breaths in the sugammadex group (P = 0.008). The median (95% CI) tidal volume was 287 (256 to 335) ml after neostigmine and 359 (313 to 398) ml after sugammadex (P = 0.013). The median (95% CI) PaO2 immediately after extubation was 30.5 (22.8 to 37.1) kPa after sugammadex vs. 20.7 (12.9 to 27.5) kPa after neostigmine (P = 0.03). CONCLUSION EMGdi, tidal volume and PaO2 following tracheal extubation were increased after sugammadex compared with neostigmine, reflecting diaphragm-driven inspiration after sugammadex administration. Sugammadex may free more diaphragmatic acetylcholine receptors than neostigmine, which has an indirect effect.
引用
收藏
页码:49 / 57
页数:9
相关论文
共 6 条
  • [1] Diaphragmatic and intercostal electromyographic activity during neostigmine, sugammadex and neostigmine-sugammadex-enhanced recovery after neuromuscular blockade A randomised controlled volunteer study
    Cammu, Guy
    Schepens, Tom
    De Neve, Nikolaas
    Wildemeersch, Davina
    Foubert, Luc
    Jorens, Philippe G.
    EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2017, 34 (01) : 8 - 15
  • [2] Functional respiratory imaging after neostigmine- or sugammadex-enhanced recovery from neuromuscular blockade in the anesthetised rat: a randomised controlled pilot study
    Schepens, Tom
    Cammu, Guy
    Maes, Sabine
    Desmedt, Benny
    Vos, Wim
    Deseure, Kristof
    REVISTA BRASILEIRA DE ANESTESIOLOGIA, 2017, 67 (05): : 443 - 449
  • [3] Respiratory muscle activity after spontaneous, neostigmine- or sugammadex-enhanced recovery of neuromuscular blockade: a double blind prospective randomized controlled trial
    Schepens, Tom
    Janssens, Koen
    Maes, Sabine
    Wildemeersch, Davina
    Vellinga, Jurryt
    Jorens, Philippe G.
    Saldien, Vera
    BMC ANESTHESIOLOGY, 2019, 19 (01)
  • [4] Comparison of neostigmine vs. sugammadex for recovery of muscle function after neuromuscular block by means of diaphragm ultrasonography in microlaryngeal surgery A randomised controlled trial
    Cappellini, Iacopo
    Ostento, Daniele
    Loriga, Beatrice
    Tofani, Lorenzo
    De Gaudio, Angelo R.
    Adembri, Chiara
    EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2020, 37 (01) : 44 - 51
  • [5] Therapeutic doses of neostigmine, depolarising neuromuscular blockade and muscle weakness in awake volunteers: a double-blind, placebo-controlled, randomised volunteer study
    Kent, N. B.
    Liang, S. S.
    Phillips, S.
    Smith, N. A.
    Khandkar, C.
    Eikermann, M.
    Stewart, P. A.
    ANAESTHESIA, 2018, 73 (09) : 1079 - 1089
  • [6] Repeat dosing of rocuronium 1.2 mg kg-1 after reversal of neuromuscular block by sugammadex 4.0 mg kg-1 in anaesthetized healthy volunteers: a modelling-based pilot study
    Cammu, G.
    de Kam, P. -J.
    De Graeve, K.
    van den Heuvel, M.
    Suy, K.
    Morias, K.
    Foubert, L.
    Grobara, P.
    Peeters, P.
    BRITISH JOURNAL OF ANAESTHESIA, 2010, 105 (04) : 487 - 492